Ethics in academia and the pharmaceutical industry

Date
2023-03-14
Authors
Ghaemi, Nassir
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract

[Note: The slide presentation is not available from this event.] Many academics in medicine assume that they hold a higher ethical standard than the pharmaceutical industry. Some of this assumption has to do with the presumed not-for-profit nature of academia and the for-profit nature of the pharmaceutical industry. In this discussion, based on my personal experience in both settings, I will contrast and compare the ethical standards of the two groups. I will conclude that they are both ethically challenged with different drawbacks. In academia, the usual ethical problem is an excessive focus on power and prestige; in the pharmaceutical industry, as is well known, the ethical problem is the profit motive. Both are highly problematic, with different causes producing the same effects: the interests of the public are sacrificed for the desires of academics and the pharmaceutical industry. Different strengths also exist: Academic freedom of thought allows for free public expression of ideas, but, combined with tenure and the wish for inclusion in the status quo power structure, it leads to self-censorship and a conservatism of thinking. Academic life begins with freethinking and ends in group think. The pharmaceutical industry is much more open to new ideas because it is not attached to any idea; its main test is practical utility in the marketplace. Hence, it is, paradoxically, much more innovative than academia, but this innovation is only tied to commercial results. Many public health needs are ignored due to non-commercial potential.

General Notes
[Note: The slide presentation is not available from this event.] Tuesday, March 14, 2023; noon to 1 p.m. (Central Time); via Zoom. "Ethics in Academia and the Pharmaceutical Industry: Personal Experience". Nassir Ghaemi, M.D., M.P.H., Professor of Psychiatry and Pharmacology at Tufts University School of Medicine School and Director of the Mood Disorder Clinic and the Psychopharmacology Consultation Clinic at Tufts Medical Center, Boston, Massachusetts.
Table of Contents
Citation
Related URI